Skip to main navigation Skip to search Skip to main content

Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530] (Clinical Lymphoma, Myeloma and Leukemia (2024) 24(8) (523–530), (S2152265024001344), (10.1016/j.clml.2024.03.011))

  • Kathryn Lurain
  • , Talal El Zarif
  • , Ramya Ramaswami
  • , Amin H. Nassar
  • , Elio Adib
  • , Noha Abdel-Wahab
  • , Nikita Chintapally
  • , Claire E. Drolen
  • , Tatyana Feldman
  • , Tarek Haykal
  • , Caroline A. Nebhan
  • , Swetha Kambhampati
  • , Mingjia Li
  • , Arjun Mittra
  • , Michael Lorentsen
  • , Chul Kim
  • , Alexandra Drakaki
  • , Michael Morse
  • , Douglas B. Johnson
  • , Ankit Mangla
  • Christopher Dittus, Praful Ravi, Robert A. Baiocchi, Elizabeth Y. Chiao, Paul G. Rubinstein, Sarvari V. Yellapragada, Ann S. LaCasce, Guru P. Sonpavde, Abdul Rafeh Naqash, Alex F. Herrera
  • National Institutes of Health
  • Yale University
  • Brigham and Women’s Hospital
  • University of Texas MD Anderson Cancer Center
  • Washington Hospital Center
  • University of California at Los Angeles
  • Duke University
  • Ohio State University
  • Vanderbilt University
  • City of Hope National Med Center
  • University of North Carolina at Chapel Hill
  • MedStar Georgetown University Hospital
  • Case Western Reserve University
  • Dana-Farber Cancer Institute
  • Stroger Hospital of Cook County
  • Department of Veterans Affairs
  • University of Oklahoma

Research output: Contribution to journal › Comment/debate

Abstract

The authors regret that Talal El Zarif was not acknowledged as co-first author and Abdul Rafeh Naqash was not acknowledged as co-senior author. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)873
Number of pages1
JournalClinical Lymphoma, Myeloma and Leukemia
Volume24
Issue number12
DOIs
StatePublished - Dec 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530] (Clinical Lymphoma, Myeloma and Leukemia (2024) 24(8) (523–530), (S2152265024001344), (10.1016/j.clml.2024.03.011))'. Together they form a unique fingerprint.

Cite this